Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. More Details
Undervalued established dividend payer.
Share Price & News
How has Fresenius SE KGaA's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: FRE is less volatile than 75% of German stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: FRE's weekly volatility (2%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: FRE exceeded the German Healthcare industry which returned 0.4% over the past year.
Return vs Market: FRE underperformed the German Market which returned 44% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Fresenius SE KGaA's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 days ago | Simply Wall StShould You Think About Buying Fresenius SE & Co. KGaA (ETR:FRE) Now?
2 weeks ago | Simply Wall StDoes Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?
1 month ago | Simply Wall StFresenius SE & Co. KGaA (ETR:FRE) Is An Attractive Dividend Stock - Here's Why
Is Fresenius SE KGaA undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: FRE (€38.63) is trading below our estimate of fair value (€129.5)
Significantly Below Fair Value: FRE is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: FRE is good value based on its PE Ratio (12.6x) compared to the DE Healthcare industry average (32.1x).
PE vs Market: FRE is good value based on its PE Ratio (12.6x) compared to the German market (27.8x).
Price to Earnings Growth Ratio
PEG Ratio: FRE is poor value based on its PEG Ratio (1.4x)
Price to Book Ratio
PB vs Industry: FRE is good value based on its PB Ratio (1.3x) compared to the DE Healthcare industry average (1.6x).
How is Fresenius SE KGaA forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FRE's forecast earnings growth (9% per year) is above the savings rate (0.07%).
Earnings vs Market: FRE's earnings (9% per year) are forecast to grow slower than the German market (20.7% per year).
High Growth Earnings: FRE's earnings are forecast to grow, but not significantly.
Revenue vs Market: FRE's revenue (4.8% per year) is forecast to grow slower than the German market (5.3% per year).
High Growth Revenue: FRE's revenue (4.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: FRE's Return on Equity is forecast to be low in 3 years time (10.5%).
How has Fresenius SE KGaA performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: FRE has high quality earnings.
Growing Profit Margin: FRE's current net profit margins (4.7%) are lower than last year (5.3%).
Past Earnings Growth Analysis
Earnings Trend: FRE's earnings have grown by 5.4% per year over the past 5 years.
Accelerating Growth: FRE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: FRE had negative earnings growth (-9.4%) over the past year, making it difficult to compare to the Healthcare industry average (2%).
Return on Equity
High ROE: FRE's Return on Equity (10.8%) is considered low.
How is Fresenius SE KGaA's financial position?
Financial Position Analysis
Short Term Liabilities: FRE's short term assets (€15.8B) exceed its short term liabilities (€13.2B).
Long Term Liabilities: FRE's short term assets (€15.8B) do not cover its long term liabilities (€27.4B).
Debt to Equity History and Analysis
Debt Level: FRE's debt to equity ratio (75.8%) is considered high.
Reducing Debt: FRE's debt to equity ratio has reduced from 77.9% to 75.8% over the past 5 years.
Debt Coverage: FRE's debt is well covered by operating cash flow (33.2%).
Interest Coverage: FRE's interest payments on its debt are well covered by EBIT (6.8x coverage).
What is Fresenius SE KGaA current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: FRE's dividend (2.28%) is higher than the bottom 25% of dividend payers in the German market (1.07%).
High Dividend: FRE's dividend (2.28%) is low compared to the top 25% of dividend payers in the German market (3.21%).
Stability and Growth of Payments
Stable Dividend: FRE's dividends per share have been stable in the past 10 years.
Growing Dividend: FRE's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (28.7%), FRE's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: FRE's dividends in 3 years are forecast to be well covered by earnings (25.3% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Stephan Sturm (57 yo)
Mr. Stephan Sturm serves as Chairman of the Management Board, Chief Executive Officer and President at Fresenius Management SE, the General Partner of Fresenius SE & Co KGaA since July 1, 2016 and its Memb...
CEO Compensation Analysis
Compensation vs Market: Stephan's total compensation ($USD7.20M) is above average for companies of similar size in the German market ($USD5.27M).
Compensation vs Earnings: Stephan's compensation has been consistent with company performance over the past year.
Experienced Management: FRE's management team is seasoned and experienced (6 years average tenure).
Experienced Board: FRE's board of directors are considered experienced (4.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Fresenius SE & Co. KGaA's company bio, employee growth, exchange listings and data sources
- Name: Fresenius SE & Co. KGaA
- Ticker: FRE
- Exchange: XTRA
- Founded: 1912
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: €21.538b
- Shares outstanding: 557.54m
- Website: https://www.fresenius.com
Number of Employees
- Fresenius SE & Co. KGaA
- Else-Kröner-Strasse 1
- Bad Homburg vor der Höhe
Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. The company operates through four segments: Fr...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/10 19:30|
|End of Day Share Price||2021/04/09 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.